Clinical Trials Directory

Trials / Completed

CompletedNCT03804632

Assessment of Asthma Control Level in Primary Care Setting in Malaysia

A Prospective Observational Multi Center Study to Assess the Level of Asthma Control at Government Health Clinics (Klinik Kesihatan) in Malaysia.

Status
Completed
Phase
Study type
Observational
Enrollment
1,011 (actual)
Sponsor
AstraZeneca · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

A prospective observational multi center study to assess the level of asthma control at Primary Care Setting; government health clinics (Klinik Kesihatan) in Malaysia. The specific objective of the study is to assess, in real-life clinical practice in Malaysia, the level of asthma control and the potential risk factors for uncontrolled disease in asthma patients treated at government health clinics.

Detailed description

Despite the availability of GINA global guideline on asthma management which is widely referred by health care providers in Malaysia, the control of asthma is still a critical challenge. According to National Health and Morbidity Survey 2011, the prevalence of asthma in Malaysia is at 6.3%. Based on self-rated health status, 5.5% of patients were reported to be in good health whereas 9.9% reported poor health status although medications such as inhaled corticosteroids (ICS) and long-acting beta agonists (LABA) are widely available for effective asthma management. There is limited data to assess the level of asthma control at the Primary Care Setting in Malaysia which includes current clinical manifestation and future risk of exacerbation. Given the lack of data on Asthma control level, the awareness on the current disease control level will assist to properly characterise the patients based on GINA control level thus leading to appropriate diagnosis and treatment. The specific objective of the study is to assess, in real-life clinical practice in Malaysia, the level of GINA-defined asthma control and the potential risk factors for uncontrolled disease in asthma patients.

Conditions

Timeline

Start date
2017-10-23
Primary completion
2018-06-06
Completion
2018-06-06
First posted
2019-01-15
Last updated
2019-05-31

Locations

10 sites across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT03804632. Inclusion in this directory is not an endorsement.